SVB Wealth LLC Sells 2,419 Shares of Danaher Corporation $DHR

SVB Wealth LLC decreased its position in shares of Danaher Corporation (NYSE:DHR – Free Report) by 20.6% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 9,333 shares of the conglomerate’s stock after selling 2,419 shares during the period. SVB Wealth LLC’s holdings in Danaher were worth $2,068,000 at the end of the most recent reporting period.

Several other large investors have also recently made changes to their positions in the company. BlackRock Inc. purchased a new position in Danaher during the 2nd quarter valued at approximately $10,492,520,000. Wellington Management Group LLP raised its holdings in shares of Danaher by 10.4% during the 2nd quarter. Wellington Management Group LLP now owns 16,316,834 shares of the conglomerate’s stock worth $3,108,031,000 after acquiring an additional 1,542,310 shares in the last quarter. Jupiter Topco LLC purchased a new stake in shares of Danaher during the 2nd quarter worth approximately $1,456,317,000. Generation Investment Management LLP purchased a new stake in shares of Danaher during the 2nd quarter worth approximately $1,287,949,000. Finally, Bank of America Corp DE bought a new position in shares of Danaher during the 2nd quarter valued at approximately $993,846,000. 79.05% of the stock is owned by institutional investors.

Danaher Price Performance

NYSE:DHR opened at $233.16 on Monday. The firm has a market capitalization of $164.04 billion, a price-to-earnings ratio of 38.16, a PEG ratio of 2.93 and a beta of 0.76. The company has a debt-to-equity ratio of 0.45, a current ratio of 1.63 and a quick ratio of 1.29. The business has a 50 day simple moving average of $222.56 and a 200-day simple moving average of $201.52. Danaher Corporation has a 1 year low of $160.93 and a 1 year high of $242.80.

Danaher (NYSE:DHR – Get Free Report) last released its earnings results on Wednesday, October 21st. The conglomerate reported $2.11 earnings per share for the quarter, beating the consensus estimate of $1.92 by $0.19. Danaher had a return on equity of 11.17% and a net margin of 16.91%. The firm had revenue of $6.55 billion for the quarter, compared to the consensus estimate of $6.56 billion. During the same quarter in the previous year, the company posted $1.89 EPS. The company’s revenue for the quarter was up 8.3% compared to the same quarter last year. Equities analysts forecast that Danaher Corporation will post 8.59 EPS for the current year.

Danaher Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, October 30th. Shareholders of record on Wednesday, September 30th were paid a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a yield of 0.7%. The ex-dividend date of this dividend was Wednesday, September 30th. Danaher’s payout ratio is presently 26.19%.

Insider Buying and Selling at Danaher

In other Danaher news, EVP Gregory Milosevich sold 2,100 shares of the business’s stock in a transaction on Monday, November 9th. The shares were sold at an average price of $230.62, for a total transaction of $484,302.00. Following the transaction, the executive vice president owned 22,367 shares in the company, valued at $5,158,277.54. The trade was a 8.58% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, CAO Christopher Bouda sold 7,598 shares of the stock in a transaction on Wednesday, October 28th. The shares were sold at an average price of $234.56, for a total transaction of $1,782,186.88. Following the completion of the sale, the chief accounting officer directly owned 9,107 shares in the company, valued at approximately $2,136,137.92. This represents a 45.48% decrease in their position. The SEC filing for this sale provides additional information. 10.80% of the stock is owned by insiders.

Wall Street Analyst Weigh In

A number of research firms recently weighed in on DHR. Wells Fargo & Company cut their target price on shares of Danaher from $212.00 to $195.00 and set an “equal weight” rating for the company in a report on Wednesday, July 22nd. JPMorgan Chase & Co. upped their price target on shares of Danaher from $250.00 to $270.00 and gave the company an “overweight” rating in a research note on Thursday, October 22nd. TD Cowen increased their price objective on shares of Danaher from $255.00 to $270.00 and gave the company a “buy” rating in a research report on Thursday, October 22nd. Barclays lifted their price objective on shares of Danaher from $255.00 to $260.00 and gave the stock an “overweight” rating in a research note on Thursday, October 22nd. Finally, Deutsche Bank restated a “buy” rating and issued a $240.00 target price on shares of Danaher in a report on Wednesday, July 22nd. Eighteen equities research analysts have rated the stock with a Buy rating and five have given a Hold rating to the company’s stock. According to data from MarketBeat, Danaher currently has an average rating of “Moderate Buy” and an average price target of $242.91.

View Our Latest Stock Report on DHR

Danaher Profile

(Free Report)

Danaher is a global science and technology company that develops and supplies products and services for biotechnology, life sciences, and diagnostics markets. Its offerings include instruments, reagents, consumables, software, and services used in research, drug development and manufacturing, and clinical testing. The company’s businesses include well-known brands such as Cytiva and Pall in bioprocessing and filtration, Beckman Coulter in laboratory and clinical diagnostics, Cepheid in molecular diagnostics, and Leica Microsystems in microscopy.

Further Reading

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR – Free Report).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.